Senti Biosciences Holdings, Inc. (SNTI) stock
SNTINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.10−0.04 (-28.68%)
Close on Nov 17, 2026Market cap $3.02MP/E –Yield –
Senti Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Senti Biosciences's enterprise value was -$1.57M on Nov 11, 2026, against $46.39M a year earlier. Over the last 5 years it ranged from -$55.42M to $46.39M, with a median of -$14.57M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$1.57M | -110.4% |
| 2025 | Dec 31, 2025 | $15.10M | +632.9% |
| 2024 | Dec 31, 2024 | $2.06M | – |
| 2023 | Dec 29, 2023 | -$10.04M | – |
| 2022 | Dec 30, 2022 | -$53.41M | – |
See a number that looks wrong?